Harper Meds
Harper Meds connects patients with named clinical networks for compounded GLP-1 care. Its June 2026 FDA letter, pharmacy identity and mixed program terms deserve attention before enrollment.
Review by Leah Garner, clinical-evidence editor · Updated October 2026
The short version
Request the actual prescriber, preparation and pharmacy before relying on an instant assessment or broad support claim. The direct FDA labeling record and unclear program-specific terms are material considerations.
Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
FDA warning letter on record: Letter 728281 · June 2026
Harper Meds is operated by Nexus Health Solutions and offers compounded semaglutide and tirzepatide through third-party clinicians. The current footer distinguishes the platform from production and acknowledges that compounded medications are not FDA-approved. Its short assessment is described as preapproval, which should not be confused with the clinician’s final decision to prescribe. A starting program amount and convenient delivery do not identify the exact formulation, administration route or dose. Those details need to be established in the individual prescription and care agreement.
What Harper Meds prescribes, by goal
Weight
- SemaglutideFDA-approved
Listed by the seller; no price we hold.
- TirzepatideFDA-approved
Listed by the seller; no price we hold.
Current public material names compounded semaglutide and tirzepatide but does not provide a complete preparation and dose schedule for the advertised program. Its guarantee section refers to weekly semaglutide doses without establishing the route of every current prescription. Ask for the actual formulation and why compounding is appropriate for the patient rather than assuming it is equivalent to a branded product. A percentage weight-loss target in a refund condition is also not a prediction or medical reason to continue an unsuitable treatment.
Who prescribes
A licensed clinician
The current site identifies Wasef Health and Beluga Health as the clinical networks, while its terms and consent give further detail about Beluga’s role. The actual assigned clinician is not identified on the homepage. The provider’s name and credentials should be supplied as care begins, rather than assumed from the platform’s general medical-doctor wording. Ask which professional practice is responsible for ongoing treatment and how clinical records transfer if care changes. A marketing preapproval does not create a clinical relationship or guarantee a prescription.
The public process begins with an assessment followed by review by a licensed clinician. Ongoing access is described through a secure portal that allows messages at any time. The linked asynchronous consent also says patient information is not monitored around the clock, so messaging access should not be treated as a guaranteed immediate clinical response. Ask how dose changes, side effects and routine follow-up are reviewed. A scheduled shipment is a fulfillment event rather than proof of a live medical appointment or a complete reassessment every month.
Are labs required?
Not mentioned
The homepage FAQ says bloodwork is not required but recommends it, and patients may submit recent results with their assessment. That statement does not establish a free panel or mean additional testing could never be clinically appropriate. Discuss the relevant medical history and whether the provider needs further information for the specific prescription. The terms also contain testing provisions under a testosterone-program heading, which should not automatically become the weight-care laboratory plan. Ask who reviews results and what any separate testing costs.
Ready to start with Harper Meds?
Prices and plans are set on the seller's own site.
What it claims, and what it cites
FDA sent Nexus Health Solutions doing business as Harper Meds a June 2026 warning after reviewing the website in March. It concerned misleading compounder identity, claims suggesting approval or evaluation and the phrase FDA-licensed compounding facilities. That is an advertising and misbranding record, not a finding that every prescription was contaminated. Current pages acknowledge unapproved compounded status but still use 503A outsourcing terminology that needs clarification. The actual pharmacy is not identified in the reviewed current material. Website changes alone do not establish FDA confirmation that the earlier concerns are resolved.
How it bills
The expanded FAQ says the program starts at $149 monthly with consultation, prescription, medication and shipping, without mapping that figure to every ingredient, dose and route. It describes automatic monthly shipments with advance notification and no long-term contract or cancellation fee. Payment is held pending physician approval and pharmacy transmission, according to the FAQ. A separate outcome guarantee has detailed sixteen-week requirements and verification conditions, while other terms describe a testosterone program. Obtain the actual weight-treatment agreement and refund cutoff rather than treating those different provisions as one unconditional promise.
For and against
- For: The platform identifies its clinical networks
- For: Payment approval and recurring shipment language are available
- For: The current pages acknowledge compounded status
- Against: A direct FDA labeling and advertising warning is relevant
- Against: The actual dispensing pharmacy is not identified
- Against: Mixed program terms make scope difficult to judge
- Against: The starting program amount lacks a complete prescription mapping
The evidence behind what it sells
Right for
A patient willing to verify the full clinical and dispensing arrangement and obtain the applicable weight-program agreement before enrolling.
Look elsewhere if
Someone expecting instant preapproval, portal access or a conditional outcome guarantee to assure a prescription, immediate care or a refund.
Other sellers for weight
Premium Health
Also prescribes Semaglutide, Tirzepatide.
JRNYS
Also prescribes Semaglutide, Tirzepatide.
LifeMD
Also prescribes Semaglutide, Tirzepatide.
Harper Meds
Frequently asked questions
- Does an instant assessment guarantee a prescription?
- No. The clinical networks retain responsibility for eligibility and the final prescribing decision.
- Does portal access mean clinical information is monitored continuously?
- No. The linked asynchronous consent expressly distinguishes message access from around-the-clock monitoring.
- What did the FDA warning address?
- It addressed website labeling and promotional representations, not a universal finding about every patient’s medication quality.
Sources
- Care and treatment: Current program, expanded pricing and support FAQ
- Care and treatment: Clinical consent, mixed program terms and conditional guarantee
- Care and treatment: Operator and privacy responsibilities
- Care and treatment: FDA direct warning to Nexus Health Solutions DBA Harper Meds
See what Harper Meds prescribes today
Harper Meds sets its own prices, plans and the states it serves. Check them before you start.